SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 33 filers reported holding SQZ BIOTECHNOLOGIES CO in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $744,706 | -51.8% | 2,758,169 | 0.0% | 0.00% | -55.6% |
| Q1 2023 | $1,544,575 | -24.3% | 2,758,169 | 0.0% | 0.01% | -25.0% |
| Q4 2022 | $2,041,045 | -67.5% | 2,758,169 | 0.0% | 0.01% | -68.4% |
| Q3 2022 | $6,288,625 | -28.3% | 2,758,169 | 0.0% | 0.04% | -20.8% |
| Q2 2022 | $8,770,977 | -33.9% | 2,758,169 | 0.0% | 0.05% | -14.3% |
| Q1 2022 | $13,266,793 | -46.1% | 2,758,169 | 0.0% | 0.06% | -37.1% |
| Q4 2021 | $24,630,000 | -38.1% | 2,758,169 | 0.0% | 0.09% | -36.0% |
| Q3 2021 | $39,773,000 | +8.6% | 2,758,169 | +8.8% | 0.14% | +13.0% |
| Q2 2021 | $36,619,000 | +6.5% | 2,534,176 | +0.8% | 0.12% | -8.9% |
| Q1 2021 | $34,390,000 | -52.8% | 2,513,924 | 0.0% | 0.14% | -56.9% |
| Q4 2020 | $72,854,000 | – | 2,513,924 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 807,827 | $23,411,000 | 1.79% |
| Alphabet Inc. | 831,389 | $24,094,000 | 1.16% |
| Artal Group S.A. | 1,606,308 | $46,551,000 | 1.00% |
| 683 Capital Management, LLC | 466,176 | $13,510,000 | 0.64% |
| MAVERICK CAPITAL LTD | 935,971 | $27,124,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 2,513,924 | $72,854,000 | 0.31% |
| CAAS CAPITAL MANAGEMENT LP | 150,000 | $4,347,000 | 0.04% |
| HRT FINANCIAL LP | 17,456 | $505,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 11,660 | $350,000 | 0.01% |
| Hudock, Inc. | 350 | $10,000 | 0.00% |